Blog
Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti
Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…
PRA Health Sciences Announces Partnership with Vineti
RALEIGH, NC and SAN FRANCISCO, CA, June 15, 2021 — PRA Health Sciences and Vineti, Inc., today announced a new...
Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies
Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain LONDON and...
Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced...
Advanced Therapies Guide – seven key challenges and proven solutions – in advanced therapy clinical trials
Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...
A new Five-minute Guide — seven key challenges in advanced therapy clinical trials
Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is...
Repost: a modern patient ID for personalized medicine
Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....
A fresh start for advanced therapy clinical trials
A look at 2020 and the coming rebound, by the numbers Even before the unpredictable year that was 2020, one...
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...
The Vineti Alliance Network — a preview of what’s next
For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...
How PTM® Label Printing keeps every patient journey on track
In advanced therapies, little labels — the in-process labels on bags of cells and final drug products — can sometimes...
A true platform is the engine for advanced therapies
A Vineti technology perspective from Chief Technology Officer Phil Calvin Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader...